ChromaCode Receives Strategic Investment From Shimadzu Future Innovation Fund



ChromaCode, a Carlsbad, CA-based genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, received a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation.

The amount of the deal was not disclosed.

View full article

More Articles Here